Although many studies suggest different degrees of myocardial and pulmonary injury during the acute infection and early follow-up [1–3],there is disagreement about cardio-pulmonary injury and functional impairment due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) during mid-term follow-up [4–8]. We attempt to evaluate the cardiopulmonary function and assess the pulmonary and myocardial injury objectively in SARS-CoV-2 survivors.
